Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ketrosden Triasmitra Tbk. (KETR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Ketrosden Triasmitra Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Ketrosden Triasmitra Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ketrosden Triasmitra Tbk. trades at Rp540 (market cap 1.49T, 24.08M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Ketrosden Triasmitra Tbk. is far larger — about 8.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Ketrosden Triasmitra Tbk. is more actively traded (24.08M versus 96.7K). Which is the better fit depends on your goals.

KETROBAT
Market Cap
1.49T167.37B
Volume
24.08M96.7K
Lot
240.78K967
Turnover
13.09B23.82M
Average Price
543.76246.34
Value
13.09B23.82M
Indicative Equilibrium Price
540248
Indicative Equilibrium Volume
1.91K41

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KETR
View details
OBAT
View details

About Ketrosden Triasmitra Tbk.

PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.

Read more on KETR

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT